FRI-364 - The number needed to treat to prevent one clinical event at 2 years after antiviral treatment for HCV with DAAs compared to IFN-based therapy
| Autor: | Krassenburg, L., Hansen, B., Zanjir, W.R., Georgie, F., Cerocchi, O., Lau, J., Van der Meer, A., Janssen, H., Feld, J. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S527-S527 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect